Veliparib is an investigational poly(ADP-ribose) polymerase (PARP) inhibitor currently studied as an oral anti-cancer agent for the treatment of various solid tumors, including ovarian and breast cancers.… Read more
Veliparib is an investigational poly(ADP-ribose) polymerase (PARP) inhibitor currently studied as an oral anti-cancer agent for the treatment of various solid tumors, including ovarian and breast cancers. This category contains high-quality reference standards, including the active pharmaceutical ingredient, process-related impurities, metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials for critical applications such as impurity profiling, analytical method validation, and rigorous quality control testing. By providing reliable benchmarks for identifying and quantifying substances, these reference standards ensure accuracy during drug development and stability studies. Stable isotope-labelled analogues are particularly valuable for mass spectrometry-based bioanalytical assays, serving as internal standards to improve precision and data integrity. Researchers rely on these well-characterized materials to maintain compliance with regulatory standards and to support the consistent evaluation of this investigational therapeutic throughout its development.